2014
DOI: 10.1093/rheumatology/keu437
|View full text |Cite
|
Sign up to set email alerts
|

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes

Abstract: BS is associated with severe ocular and articular morbidity. Visceral involvement is common and may be life-threatening. Bone dysplastic changes may show diagnostic value and suggest a previously unknown role of NOD2 in bone morphogenesis. BS is resistant to current drugs, suggesting the need for novel targeted therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
145
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 142 publications
(148 citation statements)
references
References 25 publications
3
145
0
Order By: Relevance
“…Some patients do not present with the usual clinical triad but rather several non-triad systemic, vascular, and visceral organ presentations have been reported such as fever, lymphadenopathy, hepatosplenomegaly, hypertension, and renal impairment (9,11,12). Our patient presented with profound and symptomatic hypercalcemia.…”
Section: Discussionmentioning
confidence: 68%
See 2 more Smart Citations
“…Some patients do not present with the usual clinical triad but rather several non-triad systemic, vascular, and visceral organ presentations have been reported such as fever, lymphadenopathy, hepatosplenomegaly, hypertension, and renal impairment (9,11,12). Our patient presented with profound and symptomatic hypercalcemia.…”
Section: Discussionmentioning
confidence: 68%
“…However, despite combination therapy, some patients continue to have active disease (12). The addition of adalimumab, a tumor necrosis factor alpha inhibitor, has controlled our patient's disease and her serum calcium concentration remains in the normal range.…”
Section: Discussionmentioning
confidence: 81%
See 1 more Smart Citation
“…BS (OMIM 186580) and EOS (OMIM 609464) are caused by a mutation in the NOD2 gene, located on chromosome 16q12.2-13. The NOD2 gene is encoding a protein in the NOD-like receptor family (NLR), which is expressed in macrophages, dendritic cells and epithelial cells and function as regulators of apoptosis and activation of nuclear factor kappa β (NFkβ) (3,4). The activation of NF-kβ is 4 times higher in persons with BS (5).…”
Section: Discussionmentioning
confidence: 99%
“…Previously, 208 cases of BS have been identified (62 sporadic and 146 inherited) in 2014 (3). In a recent international registry study from 2015, a further 31 cases of Blau syndrome from 11 countries were identified (20 with sporadic and 11 inherited) (4). BS/ EOS is clinically presented by granulomatous skin eruption, recurrent uveitis, and polyarthritis.…”
mentioning
confidence: 99%